Italien - Italienisch - AIFA (Agenzia Italiana del Farmaco)

the simple pharma company limited - alprostadil - alprostadil

Italien - Italienisch - AIFA (Agenzia Italiana del Farmaco)

aristo pharma gmbh - pantoprazolo - pantoprazolo

Italien - Italienisch - AIFA (Agenzia Italiana del Farmaco)

tad pharma gmbh - venlafaxina - venlafaxina

Europäische Union - Italienisch - EMA (European Medicines Agency)

taw pharma (ireland) limited - clopidogrel cloridrato - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - agenti antitrombotici - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

Europäische Union - Italienisch - EMA (European Medicines Agency)

ratiopharm gmbh - desloratadina - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - antistaminici per uso sistemico, - desloratadine ratiopharm is indicated in adults for the relief of symptoms associated with:allergic rhinitischronic idiopathic urticaria as initially diagnosed by a physician.

Italien - Italienisch - AIFA (Agenzia Italiana del Farmaco)

aristo pharma gmbh - vardenafil - vardenafil

Italien - Italienisch - AIFA (Agenzia Italiana del Farmaco)

aristo pharma gmbh - lorazepam - lorazepam

Italien - Italienisch - AIFA (Agenzia Italiana del Farmaco)

aristo pharma gmbh - lansoprazolo - lansoprazolo

Italien - Italienisch - AIFA (Agenzia Italiana del Farmaco)

zentiva italia s.r.l. - tapentadol - tapentadol

Europäische Union - Italienisch - EMA (European Medicines Agency)

teva b.v - desloratadina - rhinitis, allergic, perennial; rhinitis, allergic, seasonal - antistaminici per uso sistemico, - desloratadina teva è indicato per il sollievo dei sintomi associati:la rinite allergica;orticaria.